跳至主要内容
临床试验/NCT00741702
NCT00741702已完成不适用

Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples

Sunnybrook Health Sciences Centre0 个研究点目标入组 95 人开始时间: 2001年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95
主要终点
systolic blood pressure

研究概览

简要总结

This randomized controlled trial was designed to assess whether a community-based treatment strategy implemented by home care nurses would be effective in controlling hypertension in First Nations people with existing hypertension and type 2 diabetes.

详细描述

Two community-based strategies for controlling hypertension in First Nations people with existing hypertension and diabetes were compared. In the intervention group, a home care nurse followed a predefined treatment algorithm of pharmacologic antihypertensive therapy. In the control group, treatment decisions were made by each subject's primary care physician. The primary outcome measure was the difference between the 2 groups in teh change in systolic blood pressure after 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age>= 18 yr
  • Type 2 diabetes mellitus
  • Persistent hypertension (systolic pressure >= 130 mmHg, diastolic pressure >= 80 mm Hg, or both)

排除标准

  • use of beta blocker
  • women of child-bearing age not able to use a reliable method of birth control
  • Connective tissue disorder
  • Severe systemic or malignant disease
  • Inability to follow the protocol
  • Bilateral renal artery stenosis and other causes of secondary hypertension
  • Serum creatinine level > 250 micromol/L
  • cerebrovascular even within 6 mo
  • valvular heart disease
  • unstable angina
  • Myocardial infarction
  • Revascularization procedure within 3 mo before study recruitment
  • heart failure
  • cardiac arrhythmia requiring medical treatment or heart block
  • active hepatic disease

结局指标

主要结局

systolic blood pressure

时间窗: 12 months

次要结局

  • Change in diastolic blood pressure, change in urine albumin status and incidence of adverse events(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheldon Tobe

Principal Investigator

Sunnybrook Health Sciences Centre

相似试验